DR.WU Skincare Co., Ltd.

DR.WU Skincare Co., Ltd.

TTPEX:6523
87.90
TWD
+0.40
(+0.46%)
6.61EPS
14.81P/E
4.41BMarket Cap
Mar 10Next Earn

Total Valuation

TWD

As of June 30, 2026, DR.WU Skincare Co., Ltd. carries a market capitalization of 4.41B, placing it among publicly traded companies globally. Its enterprise value stands at 3.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.41B
Enterprise Value3.45B

Important Dates

DR.WU Skincare Co., Ltd.'s next confirmed earnings release is scheduled for March 10, 2027.

Earnings Date3/10/2027

Share Statistics

As of June 30, 2026, DR.WU Skincare Co., Ltd. has 45.05M shares outstanding.

Shares Outstanding45.05M

Valuation Ratios

As of June 30, 2026, DR.WU Skincare Co., Ltd. trades at a trailing price-to-earnings ratio of 14.81. The price-to-sales ratio is 4.10, and the price-to-book ratio stands at 3.47.

PE Ratio14.81
PS Ratio4.10
PB Ratio3.47
P/TBV Ratio3.47
P/FCF Ratio11.95
P/OCF Ratio11.75

Enterprise Valuation

As of June 30, 2026, DR.WU Skincare Co., Ltd. trades at an EV/EBITDA multiple of 10.88 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.28 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. DR.WU Skincare Co., Ltd. trades at an EV/FCF ratio of 9.31, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 3.45B versus a market cap of 4.41B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.21
EV / EBITDA10.88
EV / EBIT11.28
EV / FCF9.31

Financial Position

As of June 30, 2026, DR.WU Skincare Co., Ltd. maintains a current ratio of 3.83, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.79, indicating elevated leverage, while an interest coverage ratio of 248.34 demonstrates strong ability to service its debt obligations.

Current Ratio3.83
Quick Ratio2.91
Debt / Equity2.79
Debt / EBITDA0.11
Interest Coverage248.34

Financial Efficiency

TWD

Over the twelve months ended June 30, 2026, DR.WU Skincare Co., Ltd. posted a return on equity (ROE) of 22.06, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 17.09 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 17.11, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 21.52, useful for judging operating efficiency across full business cycles. The company generates approximately 10.44M in revenue per employee across its workforce of 103.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.06 indicates how many times DR.WU Skincare Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)22.06
Return on Assets (ROA)17.11
Return on Invested Capital (ROIC)17.09
Return on Capital Employed (ROCE)21.52
Revenue Per Employee10.44M
Employee Count103.00
Inventory Turnover2.06

Taxes

TWD

Over the twelve months ended June 30, 2026, DR.WU Skincare Co., Ltd. recorded 73.02M in income tax expense. That works out to an effective tax rate of 19.69, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 370.86M, leaving 297.83M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax73.02M
Effective Tax Rate19.69

Stock Price Statistics

TWD

As of the close on November 17, 2026, DR.WU Skincare Co., Ltd.'s stock has declined approximately 27.36% over the past 52 weeks. The 50-day moving average sits at 86.92, while the 200-day moving average is 99.18.

52-Week Price Change-27.36%
50-Day Moving Average86.92
200-Day Moving Average99.18

Income Statement

TWD

Over the twelve months ended June 30, 2026, DR.WU Skincare Co., Ltd. generated 1.07B in revenue and converted that into 297.83M in net income, yielding earnings per share of 6.61. EBITDA reached 317.13M, while operating income came in at 305.77M.

Revenue1.07B
Gross Profit717.19M
Operating Income305.77M
Pretax Income370.86M
Net Income297.83M
EBITDA317.13M
EBIT305.75M
Earnings Per Share (EPS)6.61

Balance Sheet

TWD

As of June 30, 2026, DR.WU Skincare Co., Ltd. holds 1.00B in cash and equivalents against 35.55M in total debt, resulting in a net debt position of -248.27M. Total book value stands at 1.27B, with working capital of 974.71M providing operational flexibility.

Cash & Cash Equivalents1.00B
Total Debt35.55M
Net Debt-248.27M
Equity (Book Value)1.27B
Book Value Per Share28.28
Working Capital974.71M

Cash Flow

TWD

DR.WU Skincare Co., Ltd. produced 375.22M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.78M in capital expenditures, free cash flow totaled 369.44M - equivalent to 8.21 per share.

Operating Cash Flow375.22M
Capital Expenditures-5.78M
Free Cash Flow369.44M
FCF Per Share8.21

Margins

Over the twelve months ended June 30, 2026, DR.WU Skincare Co., Ltd. posted a gross margin of 66.73, reflecting its pricing power and cost economics. The operating margin of 28.45 and net profit margin of 27.71 provide insight into operational efficiency.

Gross Margin66.73
Operating Margin28.45
Pretax Margin34.50
Profit Margin27.71
EBITDA Margin29.51

Dividends & Yields

TWD

Over the twelve months ended June 30, 2026, DR.WU Skincare Co., Ltd. paid dividends of 8.01 per share. The dividend payout ratio of 121.00 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 8.37, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 10.44, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to DR.WU Skincare Co., Ltd. shareholders.

Dividend Per Share8.01
Payout Ratio121.00
Shareholder Yield10.44
FCF Yield8.37

Stock Splits

DR.WU Skincare Co., Ltd.'s most recent stock split took place on May 26, 2016 with a 2:3 split ratio.

Last Split Date5/26/2016
Split Ratio2:3

Scores

As of June 30, 2026, DR.WU Skincare Co., Ltd. has an Altman Z-Score of 9.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score9.37